KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Common Equity (2016 - 2025)

Globus Medical's Common Equity history spans 15 years, with the latest figure at $4.6 billion for Q4 2025.

  • For Q4 2025, Common Equity rose 9.48% year-over-year to $4.6 billion; the TTM value through Dec 2025 reached $4.6 billion, up 9.48%, while the annual FY2025 figure was $4.6 billion, 9.48% up from the prior year.
  • Common Equity reached $4.6 billion in Q4 2025 per GMED's latest filing, up from $4.4 billion in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $4.6 billion in Q4 2025 to a low of $1.6 billion in Q1 2021.
  • Average Common Equity over 5 years is $3.0 billion, with a median of $3.0 billion recorded in 2023.
  • Peak YoY movement for Common Equity: soared 137.36% in 2023, then decreased 2.82% in 2024.
  • A 5-year view of Common Equity shows it stood at $1.7 billion in 2021, then increased by 6.03% to $1.8 billion in 2022, then soared by 116.53% to $4.0 billion in 2023, then grew by 4.49% to $4.2 billion in 2024, then grew by 9.48% to $4.6 billion in 2025.
  • Per Business Quant, the three most recent readings for GMED's Common Equity are $4.6 billion (Q4 2025), $4.4 billion (Q3 2025), and $4.3 billion (Q2 2025).